Important Information for GSK plc ADR Holders: Deadline Reminder for Securities Class Action Lawsuit
New York, NY – Rosen Law Firm, a global investor rights law firm, alerts purchasers of American Depositary Receipts (ADRs) of GSK plc (NYSE: GSK) between February 5, 2020, and August 14, 2022, both dates inclusive (the “Class Period”), of the April 7, 2025, lead plaintiff deadline in the securities class action lawsuit captioned Glassman v. GSK plc, Case No. 1:22-cv-07682 (S.D.N.Y).
About the Class Action Lawsuit:
The complaint alleges that defendants throughout the Class Period made materially false and misleading statements and failed to disclose material information and/or failed to disclose that:
- Defendants had inadequate internal controls over financial reporting;
- Defendants failed to properly account for certain costs related to the sale of its consumer healthcare business;
- As a result, the Company’s financial statements were materially false and misleading at all relevant times.
Impact on Individual Investors:
If you purchased GSK plc ADRs during the Class Period and wish to serve as lead plaintiff of the proposed class, you must file a motion with the court no later than April 7, 2025. A lead plaintiff is a representative party acting on behalf of other class members in directing the litigation. If you wish to join the litigation as a class member, you need take no action at this time.
Impact on the World:
The alleged accounting irregularities at GSK plc have raised concerns about the reliability of financial reporting practices in the pharmaceutical industry. This case serves as a reminder for investors to carefully scrutinize a company’s financial statements and disclosures, particularly during periods of significant business transactions. Additionally, the outcome of this litigation could have implications for investor protection laws and regulations.
Conclusion:
Rosen Law Firm encourages investors to carefully monitor the ongoing developments in the case, which is presently pending in the United States District Court for the Southern District of New York. For more information about the class action lawsuit against GSK plc, please contact Phillip Kim or Danielle Schardt of Rosen Law Firm toll free at 866-767-3653 or via email at [email protected] or [email protected]. You may also visit the firm’s website at
